Proteome Sciences plc (LON:PRM – Get Free Report)’s stock price reached a new 52-week low during mid-day trading on Friday . The stock traded as low as GBX 3.01 ($0.04) and last traded at GBX 2.50 ($0.03), with a volume of 15 shares traded. The stock had previously closed at GBX 3.01 ($0.04).
Proteome Sciences Stock Performance
The stock has a market cap of £7.38 million, a price-to-earnings ratio of -301.00 and a beta of 0.07. The company’s 50 day simple moving average is GBX 3.28 and its 200 day simple moving average is GBX 3.52.
About Proteome Sciences
Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.
Recommended Stories
- Five stocks we like better than Proteome Sciences
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- Analysts Predict 85% Upside for Wave Life Sciences After Rate Cut
- Utilities Stocks Explained – How and Why to Invest in Utilities
- FedEx Stock Dips: Another Reason to Fear Recession Is Near
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- The Half-Penny Revolution: Will SEC’s Reform Benefit Investors?
Receive News & Ratings for Proteome Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proteome Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
